# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002392
Filing Date
2022-03-01
Accepted
2022-03-01 06:03:15
Documents
86
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | acad-20211231.htm iXBRL | 10-K | 3622406
2 | EX-10.9 | acad-ex10_9.htm | EX-10.9 | 35953
3 | EX-10.11 | acad-ex10_11.htm | EX-10.11 | 28389
4 | EX-21.1 | acad-ex21_1.htm | EX-21.1 | 9896
5 | EX-23.1 | acad-ex23_1.htm | EX-23.1 | 10434
6 | EX-31.1 | acad-ex31_1.htm | EX-31.1 | 14874
7 | EX-31.2 | acad-ex31_2.htm | EX-31.2 | 14900
8 | EX-32.1 | acad-ex32_1.htm | EX-32.1 | 8159
9 | EX-32.2 | acad-ex32_2.htm | EX-32.2 | 8200
10 | GRAPHIC | img234459076_0.jpg | GRAPHIC | 152948
11 | GRAPHIC | img234459076_1.jpg | GRAPHIC | 39595
| Complete submission text file | 0000950170-22-002392.txt |  | 14294676

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | acad-20211231_cal.xml | EX-101.CAL | 74044
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | acad-20211231_def.xml | EX-101.DEF | 215027
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | acad-20211231_pre.xml | EX-101.PRE | 426990
15 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | acad-20211231.xsd | EX-101.SCH | 66402
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | acad-20211231_lab.xml | EX-101.LAB | 599108
80 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-20211231_htm.xml | XML | 3127926

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50768 | Film No.: 22693683
SIC: 2834 Pharmaceutical Preparations